Comprehensive Analytical Method Development and Testing Services
Our analytical partners provide comprehensive analytical capabilities required for supporting programs spanning from early preclinical to commercialization supporting process development, GLP studies and GMP campaigns. Our comprehensive suite of services includes, but is not limited to, method development, method verification/validation, reference standard certification, release testing, and impurity separation and identification.
- HPLC / GC method development for challenging separations including chiral separations
- Method development and testing using LC/MS, LC/ELSD, GC/FID, GC/MS, NMR, TGA, KF, DSC, FT-IR, Polarimeter
- Method transfer / validation
- Reference standard certification
- Separation and Characterization of impurities and degradants
- Raw material, intermediate and API release testing
- Stability studies: stability indicating method development and stability sample testing
CEO at Drug Discovery Alliances
Deborah has decades of business development experience marketing contract services, drug licensing and new technologies to the pharmaceutical industry. She founded Drug Discovery Alliances, Inc. in 2001 to connect pharmaceutical and biotech companies with top industry contractors who facilitate and speed projects. Deborah earned a Ph.D. in Medicinal Chemistry from University of North Carolina, Chapel Hill and has worked as an organic chemist for Rhone Poulenc. She subsequently worked for Accelyrs and MDL, marketing molecular modeling technologies and databases including Beilstein and Crossfire to the pharmaceutical industry.
Latest posts by Deborah Minor (see all)
- Drug Discovery Alliances at CPHI Barcelona 2023! - October 6, 2023
- Enhancing Resilience in Pharmaceutical Supply Chains with Drug Discovery Alliances - September 4, 2023
- Igniting Innovation through Supplier Diversity: Collaborate with Drug Discovery Alliances at Chemoutsourcing 2023! - August 14, 2023